Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 125

1.

Treatment of severe neurological deficits with IgG depletion through immunoadsorption in patients with Escherichia coli O104:H4-associated haemolytic uraemic syndrome: a prospective trial.

Greinacher A, Friesecke S, Abel P, Dressel A, Stracke S, Fiene M, Ernst F, Selleng K, Weissenborn K, Schmidt BM, Schiffer M, Felix SB, Lerch MM, Kielstein JT, Mayerle J.

Lancet. 2011 Sep 24;378(9797):1166-73. doi: 10.1016/S0140-6736(11)61253-1. Epub 2011 Sep 2.

PMID:
21890192
2.

The neurological syndrome in adults during the 2011 northern German E. coli serotype O104:H4 outbreak.

Magnus T, Röther J, Simova O, Meier-Cillien M, Repenthin J, Möller F, Gbadamosi J, Panzer U, Wengenroth M, Hagel C, Kluge S, Stahl RK, Wegscheider K, Urban P, Eckert B, Glatzel M, Fiehler J, Gerloff C.

Brain. 2012 Jun;135(Pt 6):1850-9. doi: 10.1093/brain/aws090. Epub 2012 Apr 26.

3.

Outbreak of Escherichia coli O104:H4 haemolytic uraemic syndrome in France: outcome with eculizumab.

Delmas Y, Vendrely B, Clouzeau B, Bachir H, Bui HN, Lacraz A, Hélou S, Bordes C, Reffet A, Llanas B, Skopinski S, Rolland P, Gruson D, Combe C.

Nephrol Dial Transplant. 2014 Mar;29(3):565-72. doi: 10.1093/ndt/gft470. Epub 2013 Nov 28.

4.

Immunoadsorption in patients with haemolytic uraemic syndrome.

Combe C, Bui HN, de Précigout V, Hilbert G, Delmas Y.

Lancet. 2012 Feb 11;379(9815):517-8; author reply 518-9. doi: 10.1016/S0140-6736(12)60228-1. No abstract available.

PMID:
22325656
5.

Immunoadsorption in patients with haemolytic uraemic syndrome.

Roukens AH, Vandenbroucke JP.

Lancet. 2012 Feb 11;379(9815):517; author reply 518-9. doi: 10.1016/S0140-6736(12)60227-X. No abstract available.

PMID:
22325655
6.

Immunoadsorption for haemolytic uraemic syndrome.

Kim JJ.

Lancet. 2011 Sep 24;378(9797):1120-2. doi: 10.1016/S0140-6736(11)61342-1. Epub 2011 Sep 2. No abstract available.

PMID:
21890191
7.

Psychiatric symptoms in patients with Shiga toxin-producing E. coli O104:H4 induced haemolytic-uraemic syndrome.

Kleimann A, Toto S, Eberlein CK, Kielstein JT, Bleich S, Frieling H, Sieberer M.

PLoS One. 2014 Jul 9;9(7):e101839. doi: 10.1371/journal.pone.0101839. eCollection 2014.

8.

Best supportive care and therapeutic plasma exchange with or without eculizumab in Shiga-toxin-producing E. coli O104:H4 induced haemolytic-uraemic syndrome: an analysis of the German STEC-HUS registry.

Kielstein JT, Beutel G, Fleig S, Steinhoff J, Meyer TN, Hafer C, Kuhlmann U, Bramstedt J, Panzer U, Vischedyk M, Busch V, Ries W, Mitzner S, Mees S, Stracke S, Nürnberger J, Gerke P, Wiesner M, Sucke B, Abu-Tair M, Kribben A, Klause N, Schindler R, Merkel F, Schnatter S, Dorresteijn EM, Samuelsson O, Brunkhorst R; Collaborators of the DGfN STEC-HUS registry.

Nephrol Dial Transplant. 2012 Oct;27(10):3807-15. doi: 10.1093/ndt/gfs394.

9.

Clinical features of critically ill patients with Shiga toxin-induced hemolytic uremic syndrome.

Braune SA, Wichmann D, von Heinz MC, Nierhaus A, Becker H, Meyer TN, Meyer GP, Müller-Schulz M, Fricke J, de Weerth A, Hoepker WW, Fiehler J, Magnus T, Gerloff C, Panzer U, Stahl RA, Wegscheider K, Kluge S.

Crit Care Med. 2013 Jul;41(7):1702-10. doi: 10.1097/CCM.0b013e31828a24a8.

PMID:
23660733
10.

Validation of treatment strategies for enterohaemorrhagic Escherichia coli O104:H4 induced haemolytic uraemic syndrome: case-control study.

Menne J, Nitschke M, Stingele R, Abu-Tair M, Beneke J, Bramstedt J, Bremer JP, Brunkhorst R, Busch V, Dengler R, Deuschl G, Fellermann K, Fickenscher H, Gerigk C, Goettsche A, Greeve J, Hafer C, Hagenmüller F, Haller H, Herget-Rosenthal S, Hertenstein B, Hofmann C, Lang M, Kielstein JT, Klostermeier UC, Knobloch J, Kuehbacher M, Kunzendorf U, Lehnert H, Manns MP, Menne TF, Meyer TN, Michael C, Münte T, Neumann-Grutzeck C, Nuernberger J, Pavenstaedt H, Ramazan L, Renders L, Repenthin J, Ries W, Rohr A, Rump LC, Samuelsson O, Sayk F, Schmidt BM, Schnatter S, Schöcklmann H, Schreiber S, von Seydewitz CU, Steinhoff J, Stracke S, Suerbaum S, van de Loo A, Vischedyk M, Weissenborn K, Wellhöner P, Wiesner M, Zeissig S, Büning J, Schiffer M, Kuehbacher T; EHEC-HUS consortium.

BMJ. 2012 Jul 19;345:e4565. doi: 10.1136/bmj.e4565.

11.

Management of an acute outbreak of diarrhoea-associated haemolytic uraemic syndrome with early plasma exchange in adults from southern Denmark: an observational study.

Colic E, Dieperink H, Titlestad K, Tepel M.

Lancet. 2011 Sep 17;378(9796):1089-93. doi: 10.1016/S0140-6736(11)61145-8. Epub 2011 Aug 24.

PMID:
21871657
12.

Microbes without frontiers: severe haemolytic-uraemic syndrome due to E coli O104:H4.

Binks S, Regan K, Richenberg J, Chevassut T.

BMJ Case Rep. 2012 Dec 21;2012. pii: bcr2012006896. doi: 10.1136/bcr-2012-006896.

13.

Epidemic profile of Shiga-toxin-producing Escherichia coli O104:H4 outbreak in Germany.

Frank C, Werber D, Cramer JP, Askar M, Faber M, an der Heiden M, Bernard H, Fruth A, Prager R, Spode A, Wadl M, Zoufaly A, Jordan S, Kemper MJ, Follin P, Müller L, King LA, Rosner B, Buchholz U, Stark K, Krause G; HUS Investigation Team.

N Engl J Med. 2011 Nov 10;365(19):1771-80. doi: 10.1056/NEJMoa1106483. Epub 2011 Jun 22.

14.

Neurological Sequelae in Adults After E coli O104: H4 Infection-Induced Hemolytic-Uremic Syndrome.

Schuppner R, Maehlmann J, Dirks M, Worthmann H, Tryc AB, Sandorski K, Bahlmann E, Kielstein JT, Giesemann AM, Lanfermann H, Weissenborn K.

Medicine (Baltimore). 2016 Feb;95(6):e2337. doi: 10.1097/MD.0000000000002337.

15.

Characterisation of the Escherichia coli strain associated with an outbreak of haemolytic uraemic syndrome in Germany, 2011: a microbiological study.

Bielaszewska M, Mellmann A, Zhang W, Köck R, Fruth A, Bauwens A, Peters G, Karch H.

Lancet Infect Dis. 2011 Sep;11(9):671-6. doi: 10.1016/S1473-3099(11)70165-7. Epub 2011 Jun 22.

PMID:
21703928
16.

Eculizumab in Typical Hemolytic Uremic Syndrome (HUS) With Neurological Involvement.

Pape L, Hartmann H, Bange FC, Suerbaum S, Bueltmann E, Ahlenstiel-Grunow T.

Medicine (Baltimore). 2015 Jun;94(24):e1000. doi: 10.1097/MD.0000000000001000.

17.

Renal and neurological involvement in typical Shiga toxin-associated HUS.

Trachtman H, Austin C, Lewinski M, Stahl RA.

Nat Rev Nephrol. 2012 Nov;8(11):658-69. doi: 10.1038/nrneph.2012.196. Epub 2012 Sep 18. Review.

PMID:
22986362
18.

Colonic ischaemia as a severe Shiga toxin/verotoxin producing Escherichia coli O104:H4 complication in a patient without haemolytic uraemic syndrome, Germany, June 2011.

Cordesmeyer S, Peitz U, Gödde N, Kasper HU, Hoffmann MW, Allemeyer E.

Euro Surveill. 2011 Jun 23;16(25). pii: 19895.

19.

Molecular epidemiology of a household outbreak of Shiga-toxin-producing Escherichia coli in Poland due to secondary transmission of STEC O104:H4 from Germany.

Januszkiewicz A, Szych J, Rastawicki W, Wołkowicz T, Chróst A, Leszczyńska B, Kuźma E, Roszkowska-Blaim M, Gierczyński R.

J Med Microbiol. 2012 Apr;61(Pt 4):552-8. doi: 10.1099/jmm.0.039289-0. Epub 2011 Dec 1.

PMID:
22135021
20.

An outbreak of Shiga toxin-producing Escherichia coli O104:H4 hemolytic uremic syndrome in Germany: presentation and short-term outcome in children.

Loos S, Ahlenstiel T, Kranz B, Staude H, Pape L, Härtel C, Vester U, Buchtala L, Benz K, Hoppe B, Beringer O, Krause M, Müller D, Pohl M, Lemke J, Hillebrand G, Kreuzer M, König J, Wigger M, Konrad M, Haffner D, Oh J, Kemper MJ.

Clin Infect Dis. 2012 Sep;55(6):753-9. doi: 10.1093/cid/cis531. Epub 2012 Jun 5.

Items per page

Supplemental Content

Write to the Help Desk